Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
97.07
+3.55 (3.80%)
At close: Nov 25, 2025, 4:00 PM EST
97.12
+0.05 (0.05%)
After-hours: Nov 25, 2025, 7:57 PM EST
Zimmer Biomet Holdings Revenue
Zimmer Biomet Holdings had revenue of $2.00B in the quarter ending September 30, 2025, with 9.71% growth. This brings the company's revenue in the last twelve months to $8.01B, up 5.47% year-over-year. In the year 2024, Zimmer Biomet Holdings had annual revenue of $7.68B with 3.85% growth.
Revenue (ttm)
$8.01B
Revenue Growth
+5.47%
P/S Ratio
2.41
Revenue / Employee
$471,229
Employees
17,000
Market Cap
19.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.68B | 284.40M | 3.85% |
| Dec 31, 2023 | 7.39B | 454.30M | 6.55% |
| Dec 31, 2022 | 6.94B | 112.60M | 1.65% |
| Dec 31, 2021 | 6.83B | 699.80M | 11.42% |
| Dec 31, 2020 | 6.13B | -1.85B | -23.24% |
| Dec 31, 2019 | 7.98B | 49.30M | 0.62% |
| Dec 31, 2018 | 7.93B | 129.60M | 1.66% |
| Dec 31, 2017 | 7.80B | 134.90M | 1.76% |
| Dec 31, 2016 | 7.67B | 1.67B | 27.85% |
| Dec 31, 2015 | 6.00B | 1.32B | 28.34% |
| Dec 31, 2014 | 4.67B | 49.90M | 1.08% |
| Dec 31, 2013 | 4.62B | 151.70M | 3.39% |
| Dec 31, 2012 | 4.47B | 19.90M | 0.45% |
| Dec 31, 2011 | 4.45B | 231.60M | 5.49% |
| Dec 31, 2010 | 4.22B | 124.80M | 3.05% |
| Dec 31, 2009 | 4.10B | -25.70M | -0.62% |
| Dec 31, 2008 | 4.12B | 223.60M | 5.74% |
| Dec 31, 2007 | 3.90B | 402.10M | 11.50% |
| Dec 31, 2006 | 3.50B | 209.30M | 6.37% |
| Dec 31, 2005 | 3.29B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
ZBH News
- 1 day ago - Zimmer Biomet Holdings (ZBH) Faces Investor Scrutiny Amid Emerging Markets Distributor Orders Cancelation, Reduced Top-Line Revenue Forecast -- Hagens Berman - GlobeNewsWire
- 5 days ago - Bragar Eagel & Squire, P.C. Is Investigating Gauzy and Zimmer Biomet and Encourages Investors to Contact the Firm - GlobeNewsWire
- 7 days ago - Zimmer Biomet Holdings, Inc. (ZBH) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 8 days ago - Could Zimmer Biomet Stock Be Your Next Buy? - Forbes
- 11 days ago - Zimmer Biomet Receives U.S. FDA Clearance for Enhanced Version of ROSA® Knee Robotic Technology - PRNewsWire
- 18 days ago - Zimmer Biomet to Present at the Annual Jefferies Global Healthcare Conference in London - PRNewsWire
- 19 days ago - Time To Buy Zimmer Biomet Stock? - Forbes
- 20 days ago - Zimmer Biomet Holdings, Inc. (ZBH) Q3 2025 Earnings Call Transcript - Seeking Alpha